首页 | 本学科首页   官方微博 | 高级检索  
     

安徽省阜阳市HIV/HCV共感染者抗病毒治疗服药依从性及影响因素分析
引用本文:范引光, 朱志伟, 马炜祥, 丁志强, 程国金, 戴色莺, 叶冬青. 安徽省阜阳市HIV/HCV共感染者抗病毒治疗服药依从性及影响因素分析[J]. 中华疾病控制杂志, 2017, 21(12): 1204-1208. doi: 10.16462/j.cnki.zhjbkz.2017.12.005
作者姓名:范引光  朱志伟  马炜祥  丁志强  程国金  戴色莺  叶冬青
作者单位:1. 安徽医科大学公共卫生学院流行病与卫生统计学系, 安徽 合肥 230032;;;2. 阜阳市京九区卫生站, 安徽 阜阳 236000;;;3. 安徽省疾病预防控制中心艾滋病防治科, 安徽 合肥 230000
基金项目:安徽省自然科学基金(1608085MH174);省级质量工程研究项目(2016jxxm0522);国家级大学生创新创业项目(201710366028)
摘    要:目的 探讨安徽省人类免疫缺陷病毒(human immunodeficiency virus,HIV)/丙型肝炎病毒(hepatitis C virus,HCV)共感染者抗病毒治疗服药依从性现状及其影响因素,为制定综合管理策略提供理论依据。方法 采用横断面研究方法,对安徽省阜阳市接受抗病毒治疗1年以上的HIV/HCV共感染者进行问卷调查,收集患者的一般信息和服药情况,采用多因素Logistic回归分析对其服药依从性的影响因素进行分析。结果 256例HIV/HCV共感染者在过去1个月内抗病毒治疗的服药不依从率为34.0%,结婚年限较长(OR=3.049,95%CI:1.435~6.481,P=0.004)、抗病毒治疗时间较长(OR=1.803,95%CI:1.251~2.599,P=0.002)和饮酒者(OR=2.512,95%CI:1.152~5.478,P=0.021)抗病毒治疗依从性较差,而女性(OR=0.180,95%CI:0.089~0.366,P<0.001)和设置服药提醒者(OR=0.315,95%CI:0.159~0.626,P=0.001)的抗病毒治疗依从性较好。结论 降低社会公众的艾滋病歧视和提高HIV/HCV共感染者抗病毒治疗的信心,是改善抗病毒治疗服药依从性的关键。

关 键 词:HIV   获得性免疫缺陷综合征   肝炎病毒   抗病毒药
收稿时间:2017-06-20
修稿时间:2017-09-10

Study on influencial factors of adherence to anti-retroviral treatment among people who co-infected with HIV/HCV in Fuyang City,Anhui Province
FAN Yin-guang, ZHU Zhi-wei, MA Wei-xiang, DING Zhi-qiang, CHENG Guo-jin, DAI Se-ying, YE Dong-qing. Study on influencial factors of adherence to anti-retroviral treatment among people who co-infected with HIV/HCV in Fuyang City, Anhui Province[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2017, 21(12): 1204-1208. doi: 10.16462/j.cnki.zhjbkz.2017.12.005
Authors:FAN Yin-guang  ZHU Zhi-wei  MA Wei-xiang  DING Zhi-qiang  CHENG Guo-jin  DAI Se-ying  YE Dong-qing
Affiliation:1. Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, China;;;2. Health Station of Jingjiu District, Fuyang City, Fuyang 236000, China;;;3. AIDS Department of Anhui Provincial Center for Disease Control and Provention, Hefei 230000, China
Abstract:Objective To investigate the adherence to anti-retroviral treatment and related factors among human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infectors. Methods In this cross-sectional study, 256 HIV and HCV co-infectors were recruited by convenience sampling method, and information about demography, taking medicine and therapy were collected and analyzed. Results A total of 256 HIV/HCV co-infectors were investigated, 34.0% of them missed dose in the last month. Multiple Logistic regression analysis showed that HIV/HCV co-infectors with long marriage (OR=3.049, 95% CI:1.435-6.481, P=0.004), longer time of treatment with antiretroviral therapy (ART) (OR=1.803, 95% CI:1.251-2.599, P=0.002), frequent alcohol consumption (OR=2.512, 95% CI:1.152-5.478, P=0.021) were risk factors of missed dose, while female (OR=0.180, 95% CI:0.089-0.366, P<0.001) and co-infectors who take a reminder method (OR=0.315, 95% CI:0.159-0.626, P=0.001) were protective factors for missed dose. Conclusions The ART adherence rate of HIV/HCV co-infectors was lower in Anhui Province, comprehensive intervention measures should be taken to promote the ART adherence.
Keywords:HIV  Acquired immunodeficiency syndrome  Hepatitis viruses  Antiviral agents
点击此处可从《中华疾病控制杂志》浏览原始摘要信息
点击此处可从《中华疾病控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号